The world is not enough - the value of increasing registry data in idiopathic pulmonary fibrosis

被引：3
作者：
Moor, C. C. [1 ]
Kreuter, M. [2 ,3 ]
Luppi, F. [4 ]
Wuyts, W. A. [5 ]
机构：
[1] Erasmus MC, Dept Resp Med, Rotterdam, Netherlands
[2] Heidelberg Univ, Ctr Interstitial & Rare Lung Dis Pneumol & Resp C, Thoraxklin, Heidelberg, Germany
[3] German Ctr Lung Res, Heidelberg, Germany
[4] Univ Milano Bicocca, Resp Unit, S Gerardo Hosp, Monza, Italy
[5] Univ Hosp Leuven, Dept Resp Med, Leuven, Belgium
来源：
RESPIRATORY RESEARCH | 2020年 / 21卷 / 01期
关键词：
PIRFENIDONE; NINTEDANIB; DIAGNOSIS; CAPACITY; OUTCOMES; SAFETY;
D O I：
10.1186/s12931-020-01377-1
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [11] Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data
    Khan, Mohammed
    Sherbini, Nahed
    Alyami, Sami
    Al-Harbi, Abdullah
    Al-Ghamdi, Majed
    Alrajhi, Suliman
    Rajendram, Rajkumar
    Al-Jahdali, Hamdan
    ANNALS OF THORACIC MEDICINE, 2023, 18 (01) : 45 - 51
  • [12] Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
    Kaunisto, Jaana
    Salomaa, Eija-Riitta
    Hodgson, Ulla
    Kaarteenaho, Riitta
    Kankaanranta, Hannu
    Koli, Katri
    Vahlberg, Tero
    Myllarniemi, Marjukka
    ERJ OPEN RESEARCH, 2019, 5 (03)
  • [13] Persistence of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis: A Pulmonary Fibrosis Foundation Patient Registry Study
    Kulkarni, Tejaswini
    Flaherty, Kevin
    Gupta, Sachin
    Tu, Yi-Hsuan
    Case, Amy Hajari
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2025, 22 (01) : 165 - 168
  • [14] Treatment of idiopathic pulmonary fibrosis with Nintedanib: an update
    Wongkarnjana, Amornpun
    Yanagihara, Toyoshi
    Kolb, Martin R. J.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (12) : 1139 - 1146
  • [15] Idiopathic Pulmonary Fibrosis: Epidemiology, Diagnosis and Outcomes
    Wakwaya, Yosafe
    Brown, Kevin K.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 357 (05) : 359 - 369
  • [16] Clinical course and management of idiopathic pulmonary fibrosis
    Quinn, Caitlin
    Wisse, Amy
    Manns, Stephenie T.
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2019, 14 (01)
  • [17] Recommendations for evaluating and managing idiopathic pulmonary fibrosis
    Provencher, Daniel M.
    Jauregui, Andrew R.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2018, 31 (09): : 21 - 26
  • [18] Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg)
    Krauss, Ekaterina
    Tello, Silke
    Wilhelm, Jochen
    Schmidt, Johanna
    Stoehr, Mark
    Seeger, Werner
    Dartsch, Ruth C.
    Crestani, Bruno
    Guenther, Andreas
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 19
  • [19] Nintedanib for Idiopathic Pulmonary Fibrosis
    Tepede, Abisola
    Yogaratnam, Dinesh
    JOURNAL OF PHARMACY PRACTICE, 2019, 32 (02) : 199 - 206
  • [20] Management of Idiopathic Pulmonary Fibrosis
    Salisbury, Margaret L.
    Wijsenbeek, Marlies S.
    CLINICS IN CHEST MEDICINE, 2021, 42 (02) : 275 - 285
12345